On March 2, 2010
Anthera IPO: Second Biotech to Price Low, but Price Isn’t Everything
Anthera Pharmaceuticals (ANTH) became the second biotech to make it out the current IPO window and the second biotech to take a haircut on its price…but that might not be as bad as it sounds.
No tags for this post.
0 Comments